Redeye views Gapwaves' Q4 2025 report as modestly positive, with results surpassing estimates on net...
Fiskars' Q4 adjusted EBIT came in below Modular Finance consensus, owing to the Other segment.
Redeye retains its positive view of Transtema. While Q4, as already announced, was weak, we are enco...
* PDUFA action date for Orviglance in July * Cash runway into Q4'26 * Fair value range updated: SEK ...
EQL Pharma redovisade ökad nettoomsättning och EBIT i det tredje kvartalet.
Given that Q4 was broadly in line excluding one-off revenue, our estimate revisions are limited over...
We believe Aktia’s outlook for 2026 was below expectations: the top line looks fine (one could argue...
* NOI -1% and rec PTP -10% vs ABGSCe * Occupancy -0.
Endomines H2 results were fairly in line with expectations, with main deviations relating to one-off...
DT’s Q4 results were largely in line with estimates as revenue declined by 6% y/y while EBITA was do...
Redeye presents its preview for Devyser’s Q4 2025 report, due on February 12.
Redeye is encouraged by Tagmaster’s solid earnings beat in the fourth quarter.
Redeye considers I-Tech's Q4 report to be soft, although the company faced relatively high set expec...
Redeye comments on Transtema’s Q4 report, showing numbers aligning with the preliminary figures.
Redeye comments on Evolution’s Q4-results which were close to our forecasts, albeit with soft revenu...
Redeye comments on Dynavox’s Q4 report released earlier this morning, which delivered another set of...
Fiskars Q4 adjusted EBIT of EUR 32.8m came 7% (EUR 2.
Redeye comments on Freja’s Q4, showing solid numbers in line with the preliminary figures.
Redeye comments on Hexatronic’s Q4 report, showing solid overall numbers driven by a further acceler...
Redeye provides an update following Coffee Stain Group’s Q3 2025/2026 report, which delivered strong...